177 related articles for article (PubMed ID: 21628081)
1. Could LogP be a principal determinant of biological activity in 18-crown-6 ethers? Synthesis of biologically active adamantane-substituted diaza-crowns.
Supek F; Ramljak TŠ; Marjanović M; Buljubašić M; Kragol G; Ilić N; Smuc T; Zahradka D; Mlinarić-Majerski K; Kralj M
Eur J Med Chem; 2011 Aug; 46(8):3444-54. PubMed ID: 21628081
[TBL] [Abstract][Full Text] [Related]
2. Antitumor potential of crown ethers: structure-activity relationships, cell cycle disturbances, and cell death studies of a series of ionophores.
Marjanović M; Kralj M; Supek F; Frkanec L; Piantanida I; Smuc T; Tusek-Bozić L
J Med Chem; 2007 Mar; 50(5):1007-18. PubMed ID: 17300184
[TBL] [Abstract][Full Text] [Related]
3. Computational structure-activity study directs synthesis of novel antitumor enkephalin analogs.
Gredicak M; Supek F; Kralj M; Majer Z; Hollósi M; Smuc T; Mlinarić-Majerski K; Horvat S
Amino Acids; 2010 Apr; 38(4):1185-91. PubMed ID: 19639251
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of antiproliferative effect of N-(alkyladamantyl)phthalimides in vitro.
Horvat M; Uzelac L; Marjanović M; Cindro N; Franković O; Mlinarić-Majerski K; Kralj M; Basarić N
Chem Biol Drug Des; 2012 Apr; 79(4):497-506. PubMed ID: 22176512
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of imidazol-2-one derivatives as potential antitumor agents.
Xue N; Yang X; Wu R; Chen J; He Q; Yang B; Lu X; Hu Y
Bioorg Med Chem; 2008 Mar; 16(5):2550-7. PubMed ID: 18226907
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and 3D-QSAR analysis of novel 2-hydrazinyl-4-morpholinothieno[3,2-d]pyrimidine derivatives as potential antitumor agents.
Zhu W; Liu Y; Zhai X; Wang X; Zhu Y; Wu D; Zhou H; Gong P; Zhao Y
Eur J Med Chem; 2012 Nov; 57():162-75. PubMed ID: 23059545
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide derivatives as potential agents against A549 lung cancer cells.
Xia Y; Dong ZW; Zhao BX; Ge X; Meng N; Shin DS; Miao JY
Bioorg Med Chem; 2007 Nov; 15(22):6893-9. PubMed ID: 17804244
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, Biological Evaluation, and Molecular Modeling of Aza-Crown Ethers.
Basok SS; Schepetkin IA; Khlebnikov AI; Lutsyuk AF; Kirichenko TI; Kirpotina LN; Pavlovsky VI; Leonov KA; Vishenkova DA; Quinn MT
Molecules; 2021 Apr; 26(8):. PubMed ID: 33921479
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of new cytotoxic azanaphthoquinone pyrrolo-annelated derivatives.
Shanab K; Schirmer E; Knafl H; Wulz E; Holzer W; Spreitzer H; Schmidt P; Aicher B; Müller G; Günther E
Bioorg Med Chem Lett; 2010 Jul; 20(13):3950-2. PubMed ID: 20537894
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationship studies of cytotoxic ester and ether anhydrovinblastine derivatives.
Zhang HK; Shao Y; Ding H; Hu LH
J Nat Prod; 2008 Oct; 71(10):1669-76. PubMed ID: 18771244
[TBL] [Abstract][Full Text] [Related]
11. Substituted quinazolines, part 3. Synthesis, in vitro antitumor activity and molecular modeling study of certain 2-thieno-4(3H)-quinazolinone analogs.
Al-Obaid AM; Abdel-Hamide SG; El-Kashef HA; Abdel-Aziz AA; El-Azab AS; Al-Khamees HA; El-Subbagh HI
Eur J Med Chem; 2009 Jun; 44(6):2379-91. PubMed ID: 18950904
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships of antineoplastic ring-substituted ether phospholipid derivatives.
Papazafiri P; Avlonitis N; Angelou P; Calogeropoulou T; Koufaki M; Scoulica E; Fragiadaki I
Cancer Chemother Pharmacol; 2005 Sep; 56(3):261-70. PubMed ID: 15856232
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, antitumor evaluation, molecular modeling and quantitative structure-activity relationship (QSAR) of some novel arylazopyrazolodiazine and triazine analogs.
El-Shafei A; Fadda AA; Khalil AM; Ameen TA; Badria FA
Bioorg Med Chem; 2009 Jul; 17(14):5096-105. PubMed ID: 19527933
[TBL] [Abstract][Full Text] [Related]
14. Crown ether-peptide construct selectively kills cancer cells.
Rotello VM
Chem Biol Drug Des; 2008 Jul; 72(1):1-2. PubMed ID: 18554255
[No Abstract] [Full Text] [Related]
15. Design, synthesis and antiproliferative activity of some new azapyranoxanthenone aminoderivatives.
Kolokythas G; Pouli N; Marakos P; Pratsinis H; Kletsas D
Eur J Med Chem; 2006 Jan; 41(1):71-9. PubMed ID: 16300857
[TBL] [Abstract][Full Text] [Related]
16. Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity.
Bolognese A; Correale G; Manfra M; Lavecchia A; Mazzoni O; Novellino E; La Colla P; Sanna G; Loddo R
J Med Chem; 2004 Feb; 47(4):849-58. PubMed ID: 14761187
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide hydrazone derivatives as potential agents against A549 lung cancer cells.
Xia Y; Fan CD; Zhao BX; Zhao J; Shin DS; Miao JY
Eur J Med Chem; 2008 Nov; 43(11):2347-53. PubMed ID: 18313806
[TBL] [Abstract][Full Text] [Related]
18. Design and QSAR study of analogs of gamma-tocotrienol with enhanced antiproliferative activity against human breast cancer cells.
Nikolic K; Agababa D
J Mol Graph Model; 2009 Apr; 27(7):777-83. PubMed ID: 19117779
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of crown ether acyl derivatives.
Febles M; Montalvão S; Crespín GD; Norte M; Padrón JM; Tammela P; Fernández JJ; Daranas AH
Bioorg Med Chem Lett; 2016 Nov; 26(22):5591-5593. PubMed ID: 27765506
[TBL] [Abstract][Full Text] [Related]
20. Novel benzylidene-9(10H)-anthracenones as highly active antimicrotubule agents. Synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
Prinz H; Ishii Y; Hirano T; Stoiber T; Camacho Gomez JA; Schmidt P; Düssmann H; Burger AM; Prehn JH; Günther EG; Unger E; Umezawa K
J Med Chem; 2003 Jul; 46(15):3382-94. PubMed ID: 12852768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]